The direct conversion of electrical energy to mechanical work by a material is relevant to a number of applications. This is illustrated by ferroelectric 'relaxors' such as Pb(Mg(1/3)Nb(2/3))O(3)-PbTiO(3) (PMN-PT; refs 5, 6): these materials exhibit a giant electromechanical (piezoelectric) response that is finding use in ultrasonic and medical applications, as well as in telecommunications. The origins of this effect are, however, still unclear. Here we show that the giant electromechanical response in PMN-PT (and potentially other ferroelectric relaxors) is the manifestation of critical points that define a line in the phase diagram of this system. Specifically, in the electric-field-temperature-composition phase diagram of PMN-PT (the composition being varied by changing the PT concentration), a first-order paraelectric-ferroelectric phase transition terminates in a line of critical points where the piezoelectric coefficient is maximum. Above this line, supercritical evolution is observed. On approaching the critical point, both the energy cost and the electric field necessary to induce ferroelectric polarization rotations decrease significantly, thus explaining the giant electromechanical response of these relaxors.
The electrocaloric effect (ECE) in inorganic thin film and organic relaxor ferroelectrics is investigated by directly measuring the ECE around room temperature. The results reveal that giant ECEs can be obtained in the high energy electron irradiated poly(vinylidene fluoride-trifluoroethylene) relaxor copolymer and in the La-doped Pb(ZrTi)O3 relaxor ceramic thin films, which are much larger than that from the normal ferroelectric counterparts. The large ECE observed, compared with normal ferroelectrics, is likely caused by the large number of disordered fluctuating polarization entities in relaxor ferroelectrics which can lead to extra entropy contributions and larger ECE.
The dielectric and thermal properties of a typical antiferroelectric (AFE) material are investigated by minimising numerically the free energy as given by the Kittel model of AFEs. The phase line of second-order phase transitions in the phase diagram is shown to change to a first-order line at the tricritical point T3cp, E3cp. The static dielectric susceptibility and the electrocaloric (EC) effect are calculated as a function of temperature and the applied electric field E. It is found that in a given range of electric fields and temperatures the EC effect has negative values but generally becomes positive above the AFE ordering temperature T0. The dielectric susceptibility shows characteristic peaks at the phase transitions between the field-induced polar and the AFE antipolar phase, and diverges at the tricritical point. We present experimental results for a negative EC effect, which have been obtained by direct EC measurements in PbZrO3 ceramics, and agree qualitatively with the above model.
Liquid-crystalline blue phases exhibit exceptional properties for applications in the display and sensor industry. However, in single component systems, they are stable only for very narrow temperature range between the isotropic and the chiral nematic phase, a feature that severely hinders their applicability. Systematic high-resolution calorimetric studies reveal that blue phase III is effectively stabilized in a wide temperature range by mixing surface-functionalized nanoparticles with chiral liquid crystals. This effect is present for two liquid crystals, yielding a robust method to stabilize blue phases, especially blue phase III. Theoretical arguments show that the aggregation of nanoparticles at disclination lines is responsible for the observed effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.